Great West Life Assurance CO Tg Therapeutics, Inc. Transaction History

Great West Life Assurance CO

$49.6 Billion
Q1 2024

A detailed history of Great West Life Assurance CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 12,471 shares of TGTX stock, worth $261,891. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,471

Previous 12,471 -0.0%

Holding current value

$261,891

Previous $212,000 10.38%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $57,683 - $182,850	6,900 Added 123.86%	12,471 $104,000
Q2 2023 Aug 10, 2023	SELL	$15.48 - $35.0 $17,198 - $38,885	-1,111 Reduced 16.63%	5,571 $139,000
Q3 2022 Nov 01, 2022	BUY	$4.57 - $8.4 $30,536 - $56,128	6,682 New	6,682 $40,000
Q2 2021 Aug 11, 2021	BUY	$32.5 - $48.96 $1,430 - $2,154	44 Added 0.66%	6,682 $259,000
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $29,168 - $38,064	-701 Reduced 9.55%	6,638 $317,000

Q3 2020 Nov 17, 2020	SELL	$18.49 - $27.24 $3.73 Million - $5.49 Million	-201,666 Reduced 96.49%	7,339 $196,000
Q3 2020 Nov 13, 2020	BUY	$18.49 - $27.24 $3.77 Million - $5.55 Million	203,709 Added 3846.47%	209,005 $5.59 Million
Q2 2020 Aug 17, 2020	SELL	$8.9 - $21.84 $836 - $2,052	-94 Reduced 1.74%	5,296 $103,000
Q4 2019 Feb 11, 2020	BUY	$5.1 - $11.2 $27,488 - $60,367	5,390 New	5,390 $59,000
Q3 2019 Oct 25, 2019	SELL	$5.38 - $8.99 $26,926 - $44,994	-5,005 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$6.27 - $8.65 $1,924 - $2,655	-307 Reduced 5.78%	5,005 $0
Q2 2018 Aug 10, 2018	BUY	$12.5 - $15.0 $66,400 - $79,680	5,312 New	5,312 $70,000
Q1 2018 May 10, 2018	SELL	$8.7 - $16.8 $94,299 - $182,095	-10,839 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$10.0 - $12.7 $108,390 - $137,655	10,839	10,839 $127,000

Others Institutions Holding TGTX

# of Institutions

272

Shares Held

88.1M

Call Options Held

2.72M

Put Options Held

1.74M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.05B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Tg Therapeutics, Inc. Transaction History